Correlation Between E L and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both E L and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining E L and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between E L Financial Corp and Helix BioPharma Corp, you can compare the effects of market volatilities on E L and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in E L with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of E L and Helix BioPharma.

Diversification Opportunities for E L and Helix BioPharma

-0.71

Correlation Coefficient

E L  Helix BioPharma

Pay attention - limited upside

The 3 months correlation between ELF and Helix is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding E L Financial Corp and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and E L is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on E L Financial Corp are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of E L i.e., E L and Helix BioPharma go up and down completely randomly.

Pair Corralation between E L and Helix BioPharma

Assuming the 90 days trading horizon E L Financial Corp is expected to generate 0.18 times more return on investment than Helix BioPharma. However, E L Financial Corp is 5.52 times less risky than Helix BioPharma. It trades about 0.09 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about -0.03 per unit of risk. If you would invest  129,384  in E L Financial Corp on September 13, 2024 and sell it today you would earn a total of  10,616  from holding E L Financial Corp or generate 8.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

E L Financial Corp  vs.  Helix BioPharma Corp

E L Financial

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in E L Financial Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, E L may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Helix BioPharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with E L and Helix BioPharma

The main advantage of trading using opposite E L and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if E L position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind E L Financial Corp and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.